August 9, 2019
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from August 2, 2019 up to and including August 8, 2019 a total of 570,565 of its own common shares were repurchased, with a weighted average purchase price of EUR 41.35. These repurchases were made under the repurchase program for capital reduction purposes, which was announced on January 29, 2019. Further details can be found via this link.
For further information, please contact:
Ben ZwirsPhilips Group Press OfficeTel.: +31 6 15213446E-mail: email@example.com
Ksenija GonciarenkoPhilips Investor RelationsTel.: +31 20 59 77055E-mail: firstname.lastname@example.org
About Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.